Increasing access to these effective evidence-based treatments would benefit our society as a whole, not just those impacted ...

Eli Lilly is set to launch its popular weight-loss drug in emerging markets, including India, Brazil, and Mexico, by mid-2025 ...

MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...

Budget hearings are over at the State Capitol, but one particular expense involving a popular weight loss drug has caught the ...

As a certified nutrition coach and clinical weight-loss practitioner, I believe the best diets for weight loss are those that ...

A naturally occurring molecule that works as effectively as other semaglutide-based drugs - without the common side effects - ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Novo Nordisk reported results on its next-generation obesity drug in diabetes patients, including data on weight loss that ...

Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.